Gryphon Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,765
Closed -$258K 269
2024
Q1
$258K Sell
4,765
-470
-9% -$25.5K 0.04% 223
2023
Q4
$280K Buy
5,235
+995
+23% +$53.2K 0.05% 195
2023
Q3
$246K Buy
4,240
+664
+19% +$38.5K 0.06% 159
2023
Q2
$229K Sell
3,576
-1,768
-33% -$113K 0.05% 175
2023
Q1
$370K Sell
5,344
-529
-9% -$36.7K 0.08% 130
2022
Q4
$423K Sell
5,873
-521
-8% -$37.5K 0.1% 111
2022
Q3
$454K Buy
6,394
+595
+10% +$42.2K 0.11% 100
2022
Q2
$447K Buy
5,799
+1,599
+38% +$123K 0.11% 106
2022
Q1
$307K Buy
4,200
+71
+2% +$5.19K 0.06% 154
2021
Q4
$257K Sell
4,129
-313
-7% -$19.5K 0.05% 174
2021
Q3
$262K Sell
4,442
-552
-11% -$32.6K 0.06% 166
2021
Q2
$321K Buy
4,994
+903
+22% +$58K 0.07% 134
2021
Q1
$257K Buy
4,091
+30
+0.7% +$1.89K 0.06% 145
2020
Q4
$252K Sell
4,061
-604
-13% -$37.5K 0.06% 134
2020
Q3
$282K Buy
+4,665
New +$282K 0.08% 122
2020
Q2
Sell
-4,626
Closed -$257K 137
2020
Q1
$257K Sell
4,626
-1,794
-28% -$99.7K 0.09% 118
2019
Q4
$412K Buy
+6,420
New +$412K 0.11% 108
2018
Q4
Sell
-5,892
Closed -$366K 196
2018
Q3
$366K Buy
5,892
+3,258
+124% +$202K 0.11% 97
2018
Q2
$146K Sell
2,634
-160
-6% -$8.87K 0.07% 102
2018
Q1
$177K Sell
2,794
-34
-1% -$2.15K 0.09% 86
2017
Q4
$173K Buy
+2,828
New +$173K 0.1% 91